🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Insuman Comb 25 40IU/ml
EU/1/97/030/046
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 25 40IU/ml
EU/1/97/030/047
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 30 100 IU/ml suspension for injection in a vial
EU/1/97/030/170-189
Insulin human hr1799 Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/063
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 100 IU/ml suspension for injection in a cartridge
EU/1/97/030/064
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 100IU/ml
EU/1/97/030/048
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 100IU/ml
EU/1/97/030/049
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 100IU/ml
EU/1/97/030/050
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 40IU/ml
EU/1/97/030/051
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Comb 50 40IU/ml
EU/1/97/030/052
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Implantable 400 IU/ml solution for infusion
EU/1/97/030/202-203
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Infusat 100IU/ml
EU/1/97/030/053
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Infusat 100IU/ml
EU/1/97/030/054
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/030
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/055
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 100 IU/ml solution for injection in a cartridge
EU/1/97/030/056
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 100 IU/ml solution for injection in a vial
EU/1/97/030/028
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 100 IU/ml solution for injection in a vial
EU/1/97/030/029
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 40 IU/ml solution for injection in a vial
EU/1/97/030/031
Insulin human Sanofi-Aventis Deutschland GmbH
Insuman Rapid 40 IU/ml solution for injection in a vial
EU/1/97/030/032
Insulin human Sanofi-Aventis Deutschland GmbH
Intelence 100 mg tablets
EU/1/08/468/1
Etravirine Janssen-Cilag International NV
Intelence 200 mg tablets
EU/1/08/468/002
Etravirine Janssen-Cilag International NV
Intelence 25 mg tablets
EU/1/08/468/003
Etravirine Janssen-Cilag International NV
Intralipid 20% w/v Emulsion for Infusion Biofine bag
PA2059/041/005
Soya bean oil, refined Fresenius Kabi Deutschland GmbH Marketed
Intralipid 20% w/v Emulsion for Infusion, Glass Bottle
PA2059/041/001
Soya bean oil Fresenius Kabi Deutschland GmbH Not marketed
Intrarosa 6.5 mg pessary
EU/1/17/1255/001
Prasterone Endoceutics S.A.
Intuniv 1 mg prolonged-release tablets
EU/1/15/1040/001-002
GUANFACINE HYDROCHLORIDE Takeda Pharmaceuticals International AG Ireland Branch
Intuniv 2 mg prolonged-release tablets
EU/1/15/1040/003-005
GUANFACINE HYDROCHLORIDE Takeda Pharmaceuticals International AG Ireland Branch
Intuniv 3 mg prolonged-release tablets
EU/1/15/1040/006-007
GUANFACINE HYDROCHLORIDE Takeda Pharmaceuticals International AG Ireland Branch
Intuniv 4 mg prolonged-release tablets
EU/1/15/1040/008-009
GUANFACINE HYDROCHLORIDE Takeda Pharmaceuticals International AG Ireland Branch
Invanz
EU/1/02/216/001
Ertapenem sodium Merck Sharp & Dohme BV,
INVEGA 12 mg prolonged-release tablets
EU/1/07/395/16-20
Paliperidone Janssen-Cilag International NV
INVEGA 3 mg prolonged-release tablets
EU/1/07/395/1-5
Paliperidone Janssen-Cilag International NV
INVEGA 6 mg prolonged-release tablets
EU/1/07/395/6-10
Paliperidone Janssen-Cilag International NV
INVEGA 9 mg prolonged-release tablets
EU/1/07/395/11-15
Paliperidone Janssen-Cilag International NV
Invokana 100 mg film-coated tablets
EU/1/13/884/001-004
Canagliflozin Janssen-Cilag International NV
Invokana 300 mg film-coated tablets
EU/1/13/884/005-008
Canagliflozin Janssen-Cilag International NV
Ionolyte solution for infusion
PA2059/042/001
Sodium acetate trihydrate, Sodium chloride, Potassium chloride, Magnesium chloride hexahydrate, Sodium hydroxide Fresenius Kabi Deutschland GmbH Not marketed
Ipratropium bromide/salbutamol Azure 0.5 mg/2.5 mg per 2.5 ml Nebuliser Solution
PA22871/033/001
Ipratropium bromide monohydrate, Salbutamol sulfate Azure Pharmaceuticals Ltd. Not marketed
Ipratropium bromide/Salbutamol Neutec 0.5 mg/2.5 mg per 2.5 ml nebuliser solution
PA23030/003/001
Ipratropium bromide monohydrate, SALBUTAMOL SULFATE Neutec Inhaler Ireland Limited Not marketed
Iqirvo 80 mg film-coated tablets
EU/1/24/1855/001
Elafibranor Ipsen Pharma
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets
EU/1/06/377/011-016
Irbesartan, Hydrochlorothiazide Sanofi Pharma Bristol-Myers Squibb SNC
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets
EU/1/06/377/001-005
Hydrochlorothiazide, Irbesartan Zentiva k.s.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg film-coated tablets
EU/1/06/377/017-022
Irbesartan, Hydrochlorothiazide Sanofi-Aventis Groupe
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets
EU/1/06/377/006-010
Irbesartan, Hydrochlorothiazide Zentiva k.s.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets
EU/1/06/377/023-028
Irbesartan, Hydrochlorothiazide Sanofi-Aventis Groupe
Irbesartan Rowa 150 mg tablets
PA0074/080/002
Irbesartan Rowa Pharmaceuticals Limited Marketed
Irbesartan Rowa 300 mg tablets
PA0074/080/003
Irbesartan Rowa Pharmaceuticals Limited Marketed
Irbesartan Rowa 75 mg tablets
PA0074/080/001
Irbesartan Rowa Pharmaceuticals Limited Marketed
Irbesartan Teva 150 mg film-coated tablets
EU/1/09/576/14-26
Irbesartan Teva Pharma B.V.
34 35 36 37 38 39 40
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.